ESMA Provides Guidance on Waivers From Pre-trade Transparency
The European Securities and Markets Authority (ESMA), the EU’s securities markets regulator, recently (17 July 2020) published an opinion providing guidance on pre-trade transparency waivers for equity and non-equity instruments. The document replaces the guidance of the Committee of European Securities Regulators and ESMA’s opinions on waivers from pre-trade transparency under the Market in Financial Instruments Directive (MiFID) I.
The guidance published recently provides stakeholders with information on ESMA’s assessment of features frequently encountered in the context of issuing opinions on waivers from pre-trade transparency over the last three years. The opinion aims to contribute to the consistent application of waivers from pre-trade transparency across the Union. The document will be updated should ESMA encounter further frequent issues in the context of assessing waiver notifications.
MiFIR sets out pre-trade transparency requirements for trading venues for equity and non-equity instruments to ensure that an efficient price discovery process is not impaired by the fragmentation of liquidity. MiFIR recognises however that there may be circumstances where such pre-trade transparency obligations may be waived.
Before granting a waiver, National Competent Authorities (NCAs) should notify ESMA of the intended use of each individual waiver and provide an information regarding its functioning. ESMA is required to issue an opinion to the NCA assessing the compatibility of the waiver with the MIFIR requirements. These opinions are not made public.
Over the last three years, ESMA assessed more than 900 notifications for waivers from pre-trade transparency for equity and non-equity instruments.
Opinion on The Assessment Of Pre-trade Transparency Waivers
Latest News from
COVID-19: Member states need to harmonise health assessments and measures18/09/2020 16:33:00
Common definitions, health criteria and methodologies are key to effectively fighting the ongoing pandemic and its economic consequences in the EU, MEPs say.
Poland: Council has to “finally act” to protect minorities and the rule of law18/09/2020 15:25:00
Disrespect for judicial independence and the rights of LGBTI persons point to “overwhelming evidence” of breaches of EU values, Parliament says.
COVID-19 vaccines: Public hearing in European Parliament18/09/2020 14:33:00
Addressing the challenges linked to securing access to safe COVID-19 vaccines will be the main topic of an online hearing on 22 September from 09.00-12.00 in the European Parliament.
Parliament requests more support for regions to make energy transition a success18/09/2020 13:25:00
MEPs are ready to start negotiations with the Council on setting up the Just Transition Fund to mitigate the social impact of greening the economy.
European Green Deal Call: €1 billion investment to boost the green and digital transition18/09/2020 12:38:00
The European Commission yesterday decided to launch a €1 billion call for research and innovation projects that respond to the climate crisis and help protect Europe's unique ecosystems and biodiversity.
EU arms exports: need for more control and transparency18/09/2020 11:33:00
EU citizens have to be better informed about their governments’ strategic choices on an issue that directly affects their security, warn MEPs.
COVID-19: EU must step up efforts to tackle medicine shortages18/09/2020 10:38:00
Parliament calls for the EU to be more self-sufficient when it comes to medicines and medical equipment so that affordable treatments are available at any time.
Parliament says shipping industry must contribute to climate neutrality18/09/2020 09:25:00
To decarbonise maritime transport, Parliament voted to include CO2 emissions from the sector in the EU Emissions Trading System.
Vote on Own Resources: MEPs clear way for COVID-19 recovery plan17/09/2020 16:33:00
MEPs accelerate the procedure that will enable the EU to borrow €750 billion for the “Next Generation EU” recovery plan.